一月 2026
- Home
- Thieme
一月 2026的Thieme市场份额分析
FAQs - Journal authors - Thieme Group Frequently Asked Questions What is Open Access? "Open Access" means that articles are freely accessible to read and download for everyone with internet access. There is no need for a subscription or an institutional license. There are no costs to readers....
Thieme(包含公司地区分支机构)
查看更多网站流量和参与度信息- thieme.de
Thieme收入截至 一月 2026为 --
Thieme主要域名产生的收入
3 年中Thieme主要域名的收入
Thieme主要域名的收入
Thieme热门域名的总访问量
了解Thieme市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Thieme热门域名的平均访问时长
分析Thieme参与度指标。
过去 3 个月的平均访问时长
子公司明细
Thieme热门域名的平均页面浏览量
了解Thieme如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Thieme 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Thieme Group partnered with IUPAC International on Jan 1st '26.The Thieme Group in collaboration with IUPAC and the Editors of SYNTHESIS, SYNLETT, SYNFACTS, and Science of Synthesis announce the Thieme - IUPAC Prize for 2026.
十月 1, 2025阅读更多
新闻Thieme Group launches Early Career Advisory Board.Thieme Chemistry's Science of Synthesis introduces first Early Career Advisory Board.
四月 30, 2022阅读更多
新闻Thieme Group partners with EIDO Healthcare Limited.Thieme EIDO INFORM, a ground-breaking product that is set to revolutionise the patient education and informed consent landscape in the country, is being introduced in the Indian market by Thieme Group, an eminent Germany-based medical and science publisher with over a decade-long notable presence in India, in collaboration with EIDO Healthcare, the UK-based market leader in digital consent solutions.
二月 25, 2022阅读更多
查看 Thieme 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。